Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
Apple
AAPL
|
+$935M |
| 3 |
Warner Bros
WBD
|
+$783M |
| 4 |
Home Depot
HD
|
+$626M |
| 5 |
Amazon
AMZN
|
+$476M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$734M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
Marathon Petroleum
MPC
|
+$180M |
| 4 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 5 |
S&P Global
SPGI
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Woori Financial
WF
$17.1B
| $333K | ﹤0.01% |
11,795
-3,888
| -25% | -$137K |
|
3977
Cocrystal Pharma
COCP
$15.4M
| $331K | ﹤0.01% |
67,450
+733
| +1% | +$3.9K |
|
|
HOFV
3978
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $331K | ﹤0.01% |
25,420
-16,743
| -40% | -$279K |
|
3979
Regis Corp
RGS
$69.3M
| $331K | ﹤0.01% |
15,335
-15,383
| -50% | -$347K |
|
3980
Oxbridge Re Holdings
OXBR
$9.64M
| $330K | ﹤0.01% |
98,851
+4,273
| +5% | +$20.2K |
|
|
CASI
3981
DELISTED
CASI Pharmaceuticals
CASI
| $329K | ﹤0.01% |
115,194
+1,088
| +1% | +$4.73K |
|
3982
Milestone Scientific
MLSS
$46.8M
| $329K | ﹤0.01% |
359,905
+6,658
| +2% | +$6.79K |
|
3983
Research Frontiers
REFR
$16.8M
| $329K | ﹤0.01% |
189,585
+1,716
| +0.9% | +$3.11K |
|
3984
Presidio Property Trust
SQFT
$2.02M
| $329K | ﹤0.01% |
10,345
+8,327
| +413% | +$280K |
|
3985
Lantern Pharma
LTRN
$33.9M
| $328K | ﹤0.01% |
57,564
+521
| +0.9% | +$3.11K |
|
3986
KLX Energy Services
KLXE
$35.1M
| $327K | ﹤0.01% |
75,600
+5,281
| +8% | +$28.1K |
|
3987
Live Ventures
LIVE
$33.5M
| $327K | ﹤0.01% |
13,102
-26
| -0.2% | -$934 |
|
|
CORR
3988
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $326K | ﹤0.01% |
129,375
-7,380
| -5% | -$19.9K |
|
3989
Equillium
EQ
$138M
| $324K | ﹤0.01% |
159,150
+1,928
| +1% | +$4.84K |
|
3990
Werewolf Therapeutics
HOWL
$18.6M
| $324K | ﹤0.01% |
79,280
-209,025
| -73% | -$954K |
|
3991
Neuropace
NPCE
$500M
| $324K | ﹤0.01% |
65,570
-51,298
| -44% | -$339K |
|
3992
Quince Therapeutics
QNCX
$31.8M
| $324K | ﹤0.01% |
731
-685
| -48% | -$484K |
|
|
IIII
3993
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $324K | ﹤0.01% |
32,969
+17,020
| +107% | +$167K |
|
3994
SELLAS Life Sciences
SLS
$2.38B
| $322K | ﹤0.01% |
144,719
+7,823
| +6% | +$22.9K |
|
3995
electroCore
ECOR
$84.7M
| $321K | ﹤0.01% |
42,064
+930
| +2% | +$6.73K |
|
|
LEV
3996
DELISTED
The Lion Electric Company
LEV
| $321K | ﹤0.01% |
76,445
+22,189
| +41% | +$130K |
|
|
PARA
3997
Banzai International
PARA
$5.77M
| $320K | ﹤0.01% |
3
+1
| +50% | +$98.3K |
|
|
AMRN
3998
Amarin Corp
AMRN
$297M
| $319K | ﹤0.01% |
10,719
| – | – |
|
|
AXDX
3999
DELISTED
Accelerate Diagnostics
AXDX
| $318K | ﹤0.01% |
32,099
-26,414
| -45% | -$233K |
|
|
OMGA
4000
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $318K | ﹤0.01% |
83,826
-189,070
| -69% | -$704K |
|
Similar funds
Geode Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
- Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
- Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
- Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
- Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
- Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
- Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.
Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.